EC Healthcare

57
Hold
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG3037S1021
HKD
0.42
0.01 (1.2%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
EC Healthcare Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-5.00
11.00
123.00
322.00
260.00
360.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
119.00
-47.00
-168.00
-134.00
80.00
13.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
706.00
645.00
608.00
603.00
616.00
574.00
Cash Flow from Investing Activities
292.00
-512.00
-715.00
-586.00
-366.00
314.00
Cash Flow from Financing Activities
-548.00
-289.00
-51.00
-80.00
158.00
-735.00
Net Cash Inflow / Outflow
450.00
-156.00
-160.00
-60.00
410.00
153.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
-1.00
1.00
2.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of EC Healthcare
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Profit Before Tax
-5.709
21.1742342899885
-26.00
-126.96%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
119.413
5.59830963967019
114.00
2033.02%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
706.212
56.4310045488104
650.00
1151.46%
Cash Flow from Investing Activities
292.746
14.1519454645595
278.00
1968.59%
Cash Flow from Financing Activities
-548.224
-11.2248168869792
-537.00
-4784.04%
Net Cash Inflow / Outflow
450.288
55.099209849563
395.00
717.23%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-0.446
-4.25892327682775
4.00
89.53%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'25
stock-summary

YoY Growth in year ended Mar 2025 is 9.34% vs 6.18% in Mar 2024

Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
706.21
645.89
9.34%